Welcome to our dedicated page for Jack Nathan Med news (Ticker: JNHMF), a resource for investors and traders seeking the latest updates and insights on Jack Nathan Med stock.
Jack Nathan Medical Corp. (JNHMF), operating as Jack Nathan Health, is frequently in the news for its operational restructuring, financial results, and strategic decisions. Company press releases highlight its transition from managing a large retail medical clinic network in Canada and Mexico to focusing on MedSpa services in Canada. News coverage often centers on how these changes affect its continuing operations and financial position.
Recent announcements describe the sale of Jack Nathan Health’s Canadian primary care clinic and licensee business to WELL Health Technologies Corp., the closure of its Mexico clinic network following the termination of its agreement with Walmart Mexico, and the resulting focus on Canadian MedSpa clinics. Financial results releases provide details on revenues from continuing MedSpa operations, discontinued operations related to Canada and Mexico, and the impact of restructuring on losses or income from continuing and discontinued segments.
Investors following JNHMF news will also see updates on audit timing, filing deadlines, and regulatory matters. The company has reported delays in filing audited annual financial statements and interim results, as well as the issuance of a Failure-to-File Cease Trade Order by the Ontario Securities Commission and its subsequent efforts to complete required filings. In addition, management commentary in news releases discusses strategic options, including evaluating future opportunities for the business in Canada and other markets.
This news feed aggregates company-issued releases so readers can review Jack Nathan Health’s financial disclosures, operational updates, and strategic announcements in one place. For those tracking JNHMF, the news page offers a way to monitor how the company’s MedSpa-focused strategy, restructuring activities, and going concern disclosures evolve over time.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF") announced that all matters voted at the annual general meeting on December 23, 2022, were approved by shareholders. All nominees for the board of directors were elected with strong support, receiving over 97% approval. Key resolutions included the reappointment of MNP LLP as auditors and amendments to the Omnibus Equity Incentive Plan, allowing grants of restricted stock units to executives. The company operates extensive healthcare networks in Canada and Mexico, enhancing patient access through clinics in Walmart locations.
Jack Nathan Medical Corp. (JNHMF) reported a 77% increase in Q3 fiscal 2023 revenues, totaling $4.2 million, compared to Q3 fiscal 2022. For the nine months ending October 31, 2022, revenues reached $11.8 million, marking a 110% growth year-over-year. Operating losses decreased from $1.5 million in Q2 to $0.9 million in Q3. Clinic operations generated 79% of revenues, reflecting successful acquisitions and reduced COVID-19 restrictions. As of October 31, 2022, JNH's cash position improved to $1.6 million, with total assets at $8.5 million and liabilities at $7.5 million.
Jack Nathan Medical Corp. (TSXV: JNH; OTCQB: JNHMF) has adjourned its annual and special meeting of shareholders (AGM) to December 23, 2022, at 1:30 p.m. Toronto time. The meeting will now be held in person at Dickinson Wright LLP, allowing shareholders to better comply with the Company’s advance notice by-law, which has extended the notice period to December 12, 2022. Jack Nathan Health operates as a significant healthcare network in Canada, providing convenient access to medical services within Walmart locations.
Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) reported Q2 FY2023 revenues of
FAQ
What is the current stock price of Jack Nathan Med (JNHMF)?
What is the market cap of Jack Nathan Med (JNHMF)?
